Atara Biotherap (ATRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -306,620 | -225,313 | -150,965 | -73,509 | -290,976 |
| Depreciation Amortization | 9,160 | 6,633 | 4,172 | 1,991 | 5,740 |
| Accounts receivable | -1,250 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -815 | -2,718 | -2,933 | -590 | 4,213 |
| Other Working Capital | 63,685 | 943 | -4,344 | -8,553 | -4,148 |
| Other Operating Activity | 55,081 | 43,816 | 30,390 | 13,617 | 49,545 |
| Operating Cash Flow | $-180,759 | $-176,639 | $-123,680 | $-67,044 | $-235,626 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -116,215 | -79,924 | -87,989 | 40,306 | 66,031 |
| PPE Investments | -4,513 | -3,912 | -3,409 | -1,333 | -5,572 |
| Investing Cash Flow | $-120,728 | $-83,836 | $-91,398 | $38,973 | $60,459 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -389 | -289 | -197 | -90 | -486 |
| Common Stock Issued | 429,649 | 250,753 | 217,029 | 25,607 | 195,967 |
| Other Financing Activity | -1,686 | -1,686 | -1,560 | -1,560 | -6,695 |
| Financing Cash Flow | $427,574 | $248,778 | $215,272 | $23,957 | $188,786 |
| Beginning Cash Position | 75,711 | 75,711 | 75,711 | 75,711 | 62,092 |
| End Cash Position | 201,798 | 64,014 | 75,905 | 71,597 | 75,711 |
| Net Cash Flow | $126,087 | $-11,697 | $194 | $-4,114 | $13,619 |
| Free Cash Flow | |||||
| Operating Cash Flow | -180,759 | -176,639 | -123,680 | -67,044 | -235,626 |
| Capital Expenditure | -4,513 | -3,912 | -3,409 | -1,333 | -5,733 |
| Free Cash Flow | -185,272 | -180,551 | -127,089 | -68,377 | -241,359 |